Be part of the knowledge.™

Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.

Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

8

LikeLikedUnlike

Episodes 1-15 of 17

Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Medical Industry Feature
Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
- Jennifer Caudle, DO
  Peer
- Komal Jhaveri, MD, FACP
  Peer
Asparaginase Therapy in Patients with ALL/LBL
Medical Industry Feature
Asparaginase Therapy in Patients with ALL/LBL
- Jennifer Caudle, DO
  Peer
- Leidy Isenalumhe, MD, MS
  Peer
Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data
Medical Industry Feature
Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Eric Klein, MD
  Peer
Examining a Therapeutic Modality for 2L+ mNSCLC
Medical Industry Feature
Examining a Therapeutic Modality for 2L+ mNSCLC
- Gates B. Colbert, MD
  Peer
- Eric Nadler, MD, MPP
  Peer
The CLL Patient Journey: From Diagnosis to Initial Treatment
Medical Industry Feature
The CLL Patient Journey: From Diagnosis to Initial Treatment
- Matt Birnholz, MD
  Peer
- Alexey Danilov, MD, PhD
  Peer
- Brian Koffman, MDCM
  Peer
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
Medical Industry Feature
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
- Matt Birnholz, MD
  Peer
- Alexey Danilov, MD, PhD
  Peer
- Brian Koffman, MDCM
  Peer
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
Medical Industry Feature
Clinical Insights into Higher-Risk MDS: Treatment Goals and Strategies
- Gates B. Colbert, MD
  Peer
- Uma Borate, MD
  Peer
- James Dugan, MD
  Peer
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
Medical Industry Feature
EMERALD Expert Views: Managing ER+/HER2-, ESR1m mBC Disease Progression Post ET+CDK4/6i
- Jennifer Caudle, DO
  Peer
- Virginia Kaklamani, MD
  Peer
- Anne O'Dea, MD
  Peer
Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
Medical Industry Feature
Considerations for Time-limited Treatment in 1L Treatment Selection Decisions
- Jennifer Caudle, DO
  Peer
- Matthew Cortese, MD, MPH
  Peer
Helping Ensure Adequate Tissue Sampling Within the MDT
Medical Industry Feature
Helping Ensure Adequate Tissue Sampling Within the MDT
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Managing Patients Within a Multidisciplinary Team Approach
Medical Industry Feature
Managing Patients Within a Multidisciplinary Team Approach
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Pre-Testing: Working Together Toward Testing
Medical Industry Feature
Pre-Testing: Working Together Toward Testing
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Interpreting Test Results and Making the Treatment Decision Within the MDT
Medical Industry Feature
Interpreting Test Results and Making the Treatment Decision Within the MDT
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Advocate for the Pathologist Within the MDT
Medical Industry Feature
Advocate for the Pathologist Within the MDT
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Patient-Centric Care for Managing Certain Manifestations of VHL Disease
Medical Industry Feature
Patient-Centric Care for Managing Certain Manifestations of VHL Disease

Program Chapters

Segment Chapters

Playlist:

Recommended